A Copper‐Based Photothermal‐Responsive Nanoplatform Reprograms Tumor Immunogenicity via Self‐Amplified Cuproptosis for Synergistic Cancer Therapy
Advanced Science · 2025
DOI: 10.1002/advs.202500652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Runzi Cheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China. Hauptthemen laut MEDLINE: Copper, Photothermal Therapy, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, Beijing Innovation Center for Engineering Science and Advanced Technology, Peking University, Medical Science and Technology Foundation of Guangdong Province.
Abstract (Originalsprache)
Studies show that intracellular accumulation of copper ions causes cuproptosis, potentially enhancing anticancer immunity. However, the induction of cuproptosis inevitably faces challenges due to low intracellular copper deliver efficiency and collateral damage to normal tissues. This paper presents a self‐amplified cuproptosis nanoplatform (CEL NP) composed of Cu 2− X S hollow nanospheres (HNSs), elesclomol (ES), and phase‐change material lauric acid (LA). Under NIR‐II laser irradiation, the photothermal energy generated by Cu 2− X S HNSs melts LA, facilitating the precise release of ES and copper ions within the tumor microenvironment. Notably, ES can traverse the cell membrane and form ES‐Cu(II) complexes, thereby enhancing copper delivery within tumor cells. Excess Cu(II) also reacts with endogenous glutathione, reducing its inhibitory effect on cuproptosis. Ultimately, this amplified cuproptosis effect can activate immunogenic cell death, eliciting a robust immune response and promoting tumor suppression. The CEL NP‐mediated release of ES and copper ions offers a novel approach for anticancer therapy through cuproptosis induction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
- Shantou University Medical College, Shantou, 515041, China.
- Southern Medical University, Guangzhou, 510515, China.
- Department of Neurosurgery, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
- Department of Ultrasound, The First Affiliated Hospital of Shantou University Medical College, Shantou, 515041, China.
ORCID-Profile: Runzi Cheng
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
- Beijing Innovation Center for Engineering Science and Advanced Technology, Peking University
- Medical Science and Technology Foundation of Guangdong Province
Zitieren
APA
Cheng, R., Li, Z., Luo, W., Chen, H., Deng, T., Gong, Z., Zheng, Q., Li, B., Zeng, Y., Wang, H., & Huang, C. (2025). A Copper‐Based Photothermal‐Responsive Nanoplatform Reprograms Tumor Immunogenicity via Self‐Amplified Cuproptosis for Synergistic Cancer Therapy. Advanced Science. https://doi.org/10.1002/advs.202500652
Vancouver
Cheng R, Li Z, Luo W, Chen H, Deng T, Gong Z, et al. A Copper‐Based Photothermal‐Responsive Nanoplatform Reprograms Tumor Immunogenicity via Self‐Amplified Cuproptosis for Synergistic Cancer Therapy. Advanced Science. 2025. doi:10.1002/advs.202500652
BibTeX
@article{Cheng2025,
author = {Cheng, Runzi and Li, Zhenhao and Luo, Weican and Chen, Hongwu and Deng, Tingting and Gong, Zhenqi and Zheng, Qing and Li, Baizhi and Zeng, Yongming and Wang, Huaiming and Huang, Cong},
title = {A Copper‐Based Photothermal‐Responsive Nanoplatform Reprograms Tumor Immunogenicity via Self‐Amplified Cuproptosis for Synergistic Cancer Therapy},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202500652}
}
EUVIMED